PPP1R14A (protein phosphatase 1 regulatory inhibitor subunit 14A) is a potent inhibitor of protein phosphatase 1 catalytic subunit (PPP1CA) that functions as a molecular switch regulating smooth muscle contraction and phosphorylation status of PPP1CA substrates 1. The protein shares ~90% sequence identity with porcine CPI17 and exhibits over 1000-fold higher inhibitory activity when phosphorylated, a critical mechanism for calcium sensitization in myometrial smooth muscle contraction 2. PPP1R14A is highly expressed in heart, prostate, testis, ovary, colon, small intestine, and pancreas 1. In pregnancy, PPP1R14A phosphorylation increases dramatically in myometrium and correlates with elevated GTP-bound RHOA in spontaneous preterm labor, suggesting a role in regulating uterine contractility 2. PPP1R14A has emerged as a disease-associated gene across multiple pathologies: it is significantly associated with idiopathic pulmonary fibrosis through Mendelian randomization analysis 3, correlates with poor gastric cancer prognosis and elevated expression in cancer-associated fibroblasts 4, associates with nivolumab resistance in head and neck squamous cell carcinoma through immune suppression mechanisms 5, and is implicated in colonic diverticulosis genetic predisposition [PMID:31351939; 63]. PPP1R14A methylation status serves as a prognostic biomarker in gastric cancer survival prediction 7.